Andrew Brauer
Optometrist · Chicago, ILNPI 1316293590
Payments from drug & device makers
Across 53 payments — averaging $84.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Visioneering Technologies, Inc.$2K
- Johnson & Johnson Vision Care, Inc.$1K
- Coopervision Inc.$431
- Alcon$252
- LKC Technologies, Inc.$82
- Biotissue Holdings Inc.$54
- plus $99 from 4 others
What the payments were for
- Consulting fees$54512%
- Speaking & faculty fees$2,05046%
- Food & beverage$1,85341%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Visioneering Technologies, Inc. | 6 | $2,134 |
| Johnson & Johnson Vision Care, Inc. | 25 | $1,415 |
| Coopervision Inc. | 9 | $431 |
| Alcon | 3 | $252 |
| LKC Technologies, Inc. | 1 | $82 |
| Biotissue Holdings Inc. | 3 | $54 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$749
- Precision7$126
- TOTAL30$109
How this compares
$4,467 in reported general payments places this provider in the 90th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 14 | $6,666 |
| Latanoprost | 45 | $490 |
| Dorzolamide Hcl | 16 | $226 |
| ValacyclovirValacyclovir Hcl | 12 | $110 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $110 |
| Timolol Maleate | 15 | $109 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chicago
- Michael ChaglasianChicago$683K
- Pamela LoweChicago$447K
- Jessilin QuintChicago$380K
- Yi PangChicago$363K
- Jennifer HarthanChicago$331K
- Jullian CerasuoloChicago$329K
- Timothy McMahonChicago$152K
- Neil HodurChicago$67K
- Katarzyna Aleszczyk VarneyChicago$65K
- James SementilliChicago$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.